No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹17.15Prev. Close
₹16.38Turnover(Lac.)
₹4.62Day's High
₹17.19Day's Low
₹16.1552 Week's High
₹19.952 Week's Low
₹9.64Book Value
₹1.53Face Value
₹10Mkt Cap (₹ Cr.)
13.98P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 8.13 | 8.13 | 8.13 | 8.13 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -6.15 | -5.31 | 2.73 | 2.83 |
Net Worth | 1.98 | 2.82 | 10.86 | 10.96 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 8.16 | 197.39 | 79.71 | 61.88 |
yoy growth (%) | -95.86 | 147.63 | 28.8 | -1.67 |
Raw materials | -3.95 | -154.62 | -57.59 | -40.72 |
As % of sales | 48.36 | 78.33 | 72.24 | 65.8 |
Employee costs | -1.05 | -5.35 | -3.32 | -3.34 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.13 | 0.71 | 0.68 | 1.13 |
Depreciation | -0.28 | -1.95 | -1.68 | -1.7 |
Tax paid | 0.8 | -1.28 | 0 | -0.62 |
Working capital | -19.52 | -3.33 | 2.94 | 3.15 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -95.86 | 147.63 | 28.8 | -1.67 |
Op profit growth | -78.18 | 5.72 | -0.76 | -7.62 |
EBIT growth | -74.28 | -5.76 | 2.65 | -15.72 |
Net profit growth | -267.66 | -183.02 | 34.97 | -39.65 |
| Particulars (Rupees in Crores.) | Mar-2012 |
|---|---|
Gross Sales | 78.91 |
Excise Duty | 0 |
Net Sales | 78.91 |
Other Operating Income | 6.88 |
Other Income | 0.25 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,737 | 98.11 | 4,28,185.32 | 705.44 | 0.9 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,408.5 | 66.77 | 1,71,766.14 | 598 | 0.46 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,333.3 | 66.68 | 1,48,922.76 | 577 | 0.14 | 2,547 | 249.82 |
Dr Reddys Laboratories Ltd DRREDDY | 1,286.3 | 23.73 | 1,10,081.07 | 90.6 | 0.61 | 4,266.4 | 377.55 |
Cipla Ltd CIPLA | 1,348.2 | 23.94 | 1,09,680.46 | 616.88 | 1.18 | 4,256.93 | 411.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
S Murali Krishna Murthy
Non Executive Director
Pramod Dnyandeo Wag He
Independent Director
Mounika Pammi
Whole-time Director
Prashant Prakash Sawant
Whole-time Director
Prakruti Prakash Sawant
Chairman & Independent Directo
Sarang Balbhimrao Patodekar
Independent Director
Ajay Vishwakarma
Company Sec. & Compli. Officer
Madhu Solanki
D No 1-8-B4 Ground Floor F3,
HIG Block-4 Street No 3,
Telangana - 500044
Tel: -
Website: http://www.ortinlabsindia.com
Email: info@ortinlabsindia.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@karvy.com
Summary
Ortin Laboratories Limited was incorporated in October, 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. The Company is a leading and predominant...
Read More
Reports by Ortin Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.